PCI – 7th June 2024
Thermofisher: Thu 29 February 2024, 11:15

Current Edition

Upcoming Events

PFS & Injectable drug devices west coast
PFS & Injectable Drug Devices East Cost
PFS & Injectable drug devices Europe
AI in Drug Discovery
Bio Trinity
Anglo Nordic
Genesis 13.11.25
BioPharma 23.10.25

Advertisement

A&M STABTEST: Fri 21 June 2024, 11:43
CDD Vault – 18.03.2025
Biopharma Group – 19th March 2025
Light Cast – 17.07.2025
QMB Innovation Centre

Korea to invest $33.4M in medical AI system

The ministry plans to carry out this medical artificial intelligence project over the course of three years. Image credit- robohub.org

The South Korean government plans to invest 35.7 billion won ($33.4 million) over the next three years to build a homegrown medical artificial intelligence (AI) system that analyzes patients’ medical data to offer personalized diagnostics and treatment plans.

The Ministry of Science, Information and Communication Technology recently held a ceremony in Seoul to formally mark the beginning of efforts to develop the Korean medical AI system dubbed “Dr. Answer,” which uses medical big data to guide doctors in their diagnosis and treatment planning, similar to IBM’s Watson.

Dr. Answer will be developed to specifically target eight maladies: breast cancer, colorectal cancer, prostate cancer, cerebrovascular disease, heart disease, epilepsy, dementia and pediatric rare refractory genetic disease.

The ministry plans to carry out this medical artificial intelligence project over the course of three years, with aims to conclude it by 2020. This year, it plans to inject 5 billion won into the project.

The state-run medical AI project will be led by Seoul’s Asan Medical Center and is to involve 25 local hospitals and medical institutions as well as 19 artificial intelligence tech software developers, including Vuno, JLK Inspection and Kakao Brain.

Newcells 3 June 2024, 15:12
Aldevron: 16th January 2025
Richter: Wed 23 October 2024, 09:03
Asychem – 10.04.2025
Taconic Biosciences – 29.04.25
Steribar – 12.05.2025
Crown Bioscience 08.09.2025
Polypure hompage